124 related articles for article (PubMed ID: 2532583)
1. [Clinico-laboratory evaluation a new sustained-release preparation of anhydrous theophylline].
Gandola L; Aiolfi S; Soccini F; Patrini G; Capellini G; Scartabellati A; Ghio L; Mauri F
Clin Ter; 1989 Dec; 131(5):293-7. PubMed ID: 2532583
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the effectiveness and safety of a controlled-release theophylline in patients with reversible and stable bronchial obstruction.
Grassi V; Nicora M; Beretta A
Int J Clin Pharmacol Res; 1987; 7(5):337-44. PubMed ID: 3667006
[TBL] [Abstract][Full Text] [Related]
3. [Prescription of Theostat 300 as a single evening dose].
Germouty J; Bida C; Moreau L
Rev Pneumol Clin; 1987; 43(5):262-5. PubMed ID: 3324266
[TBL] [Abstract][Full Text] [Related]
4. Serum theophylline concentrations and pulmonary function tests after administration of two sustained-release formulations containing theophylline in patients affected by chronic obstructive lung disease.
Fontana G; Cresci F; Lo Sapio P; Panuccio P
Int J Clin Pharmacol Res; 1987; 7(5):351-6. PubMed ID: 3667008
[TBL] [Abstract][Full Text] [Related]
5. [Clinical functional study of a new delayed-action preparation of "once a day" anhydrous theophylline in patients with chronic obstructive bronchopneumopathy].
Gatto PG; Bruzzoni A; Valenti V
Clin Ter; 1989 Jul; 130(1):45-9. PubMed ID: 2529079
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of two long-acting theophylline preparations in daily evening administration].
Holzer R
Wien Med Wochenschr; 1993; 143(2):37-42. PubMed ID: 8488685
[TBL] [Abstract][Full Text] [Related]
7. [Use of a new delayed-release anhydrous theophylline by single daily administration in the treatment of reversible bronchial obstruction. Comparison with a delayed-release preparation administered twice daily].
Baronti A; Verdiani P; Di Carlo S
Clin Ter; 1987 Sep; 122(6):437-40. PubMed ID: 2972456
[No Abstract] [Full Text] [Related]
8. Serum theophylline and ventilatory function in chronic obstructive lung disease. Comparison between two slow-release formulations of theophylline.
Tantucci C; Grassi V; Verdecchia P; Cornelli U; Sorbini CA
Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):560-4. PubMed ID: 3905630
[TBL] [Abstract][Full Text] [Related]
9. [The comparative efficacy of the prolonged-action theophylline preparations Theopek and Euphylong in elderly patients with chronic obstructive lung diseases].
Salikova VV; Nonikov VE; Belousov IuB
Ter Arkh; 1993; 65(8):41-4. PubMed ID: 8211801
[TBL] [Abstract][Full Text] [Related]
10. [Levels of blood theophylline in patients with acute bronchospasm].
Martínez MJ; Martínez B; Saucedo R; García Delgado R; García Morillas M; Puche E
Rev Clin Esp; 1989 May; 184(9):470-2. PubMed ID: 2772324
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of chronic obstructive respiratory disease with a new purified theophylline preparation in delayed-action form].
Kaik G
Wien Med Wochenschr; 1984 Apr; 134(7):163-9. PubMed ID: 6741156
[TBL] [Abstract][Full Text] [Related]
12. Treatment of reversible chronic airways obstruction with doxofylline compared with slow-release theophylline: a double-blind, randomized, multicentre trial.
Melillo G; Balzano G; Jodice F; De Felice A; Campisi V; Capone M; Di Filippo A; Foddai G; Franzone JS; Grossi E
Int J Clin Pharmacol Res; 1989; 9(6):397-405. PubMed ID: 2699466
[TBL] [Abstract][Full Text] [Related]
13. Nocturnal asthma: effect of a once per evening dose of sustained release theophylline.
Neuenkirchen H; Wilkens JH; Oellerich M; Sybrecht GW
Eur J Respir Dis; 1985 Mar; 66(3):196-204. PubMed ID: 3884358
[TBL] [Abstract][Full Text] [Related]
14. Short-acting versus a long-acting preparation of theophylline ('Xantivent') in the treatment of reversible bronchospasm.
Andrasch R; Schmitz-Schumann M
Pharmatherapeutica; 1984; 3(10):668-77. PubMed ID: 6463066
[TBL] [Abstract][Full Text] [Related]
15. Long-term therapy with sustained-release theophylline.
Myhre KI; Arnulf V; Walstad RA
Pharmatherapeutica; 1985; 4(2):92-7. PubMed ID: 3903782
[TBL] [Abstract][Full Text] [Related]
16. [Clinical effectiveness of a new preparation of sustained-release theophylline].
Corrias A; Pelosi U; Corona GB; Burrai P; Corda R
Pediatr Med Chir; 1989; 11(5):537-9. PubMed ID: 2631061
[TBL] [Abstract][Full Text] [Related]
17. [Obstructive airway diseases. Basic therapy with pure theophylline in retard form].
Pollert I
Fortschr Med; 1982 Mar; 100(12):547-50. PubMed ID: 7042500
[No Abstract] [Full Text] [Related]
18. The tolerability of a new oral controlled release theophylline preparation in patients with obstructive airways diseases.
Nolte D; Dusik B
Br J Clin Pract Suppl; 1984; 32():18-21. PubMed ID: 6432018
[No Abstract] [Full Text] [Related]
19. [Therapy of chronic obstructive respiratory syndrome with the new theophylline preparation Afonilum retard].
Dettmer HH
Fortschr Med; 1981 Jul; 99(25):1007-11. PubMed ID: 7262783
[No Abstract] [Full Text] [Related]
20. Theophylline in serum and in bronchoalveolar lavage (BAL) in atopic bronchial asthma and chronic bronchitis.
Plusa T; Józefczak E; Raczka A
Allergol Immunopathol (Madr); 1989; 17(1):29-32. PubMed ID: 2750638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]